SK C&C Supplies 'AI Brain Hemorrhage Diagnosis Solution' to Ulleungdo... "Protecting the Golden Time"

[Asia Economy Reporter Kang Nahum] SK㈜C&C announced on the 4th that it has supplied the AI-based brain hemorrhage imaging medical solution, ‘Medical Insight+ Brain Hemorrhage,’ to the Ulleung-gun Health and Medical Center.

This is the third public medical institution to open, following the Gangwon-do Pyeongchang-gun Health and Medical Center earlier this year and the Jeollabuk-do Muju-gun Health and Medical Center. Baengnyeong Hospital, located on Baengnyeongdo, the northernmost island in the West Sea, is also scheduled to open at the end of August with installation underway. Health and Medical Centers are healthcare institutions that add hospital functions to health clinics in medically underserved areas, with 15 such centers operating nationwide.

This solution, developed in-house by SK C&C, analyzes brain CT images within seconds and immediately informs medical staff of the hemorrhage location and abnormalities with over 97% accuracy. It can interpret even small and subtle hemorrhages that are easy to miss at the level of a neuro-radiology specialist.

In August last year, it became the first AI brain hemorrhage diagnostic medical device in Korea to receive Class 3 medical device approval from the Ministry of Food and Drug Safety.

In particular, distributing this solution to Ulleungdo, the main island of Dokdo located at the easternmost point of the country, is significant in terms of creating social value. The Ulleung-gun Health and Medical Center is the only medical institution on Ulleungdo, responsible for the health and safety of 9,000 residents as well as approximately 300,000 tourists annually.

Critically ill patients require rapid and accurate emergency treatment at the Health and Medical Center before being transported to mainland hospitals by helicopter and patrol boats. However, with the current medical staff size and in-house facilities, it was difficult to handle severe conditions such as brain hemorrhages.

Yoon Dongjun, Head of SK C&C Healthcare Group, said, "With the help of ‘Medical Insight+ Brain Hemorrhage’ in clinical settings, medical staff can now make fast and accurate diagnoses, enabling them to meet the golden time for brain hemorrhage treatment, known to be three hours. Moving forward, we will continue to supply this solution to regional public medical institutions to enhance the level of public medical services and create social value."

This content was produced with the assistance of AI translation services.